Ibritumomab Tiuxetan
information and resources from the National Cancer Institute
Zevalin
Accel. Approv. (clinical benefit not established) treatment of patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, including patients with Rituximab refractory follicular non-Hodgkin’s lymphoma.
IDEC Pharmaceuticals Corp Feb 19 2002
|
|
|
|
news articles
An infusion of new hope Mar 31, 2006
Globe and Mail, The drug works like a smart bomb, delivering radiation directly to tumour cells, uniting the monoclonal antibody search agent "ibritumomab tiuxetan" with the ...
Woman's last hope tied up in red tape Mar 16, 2006
Globe and Mail, Zevalin works like a smart bomb, delivering radiation directly to tumour cells, uniting the monoclonal antibody search agent "ibritumomab tiuxetan" with the ...
TRACON Pharmaceuticals Assembles Industry-Leading Management Team ... Mar 15, 2006
Yahoo! News (press release) ...of oncology products in development, including the regulatory filings that supported the approval of Rituxan® (rituximab) and Zevalin® (ibritumomab tiuxetan ...
Chemotherapy Consolidation with Zevalin(R) (90Y-Ibritumomab ... Dec 12, 2005
PR Newswire UK (press release), According to recent trial findings, the consolidation of standard chemotherapy with Zevalin(R) (90Y-Ibritumomab tiuxetan), was well-tolerated, safe and ...
New Treatment Regimen May Improve Mantle Cell Lymphoma: Presented ... Dec 14, 2005
DG News ATLANTA, GA -- December 14, 2005 -- A new study shows that chemotherapy paired with Y-ibritumomab tiuxetan (Zevalin) might improve outcomes for patients with ...
Chemotherapy Consolidation with Zevalin(R) (90Y-Ibritumomab ... Dec 12, 2005
Biotech Intelligence (press release), December 12/PRNewswire/ -- According to recent trial findings, the consolidation of standard chemotherapy with Zevalin(R) (90Y-Ibritumomab tiuxetan), was well ...
Pharmacyclics' Stock Crushed After Failed Phase III Of Xcytrin Dec 19, 2005
BioWorld Online (subscription), ...data from earlier-stage studies of Xcytrin: Phase I results showed Xcytrin injection, when given in combination with Zevalin (ibritumomab tiuxetan), was well ...
ATLANTA -- Abstracts Presented at 2005 ASH Annual Meeting Reveal ... Dec 14, 2005
dBusinessNews Atlanta (press release), ...in Atlanta, December 10-13, demonstrate that patients may benefit from earlier and consolidated use of ZEVALIN(R) (Ibritumomab Tiuxetan) radioimmunotherapy in ...
Zevalin Used in Abbreviated Chemotherapy Regimen Shows Efficacy ... Dec 16, 2005
DG News ATLANTA, GA -- December 16, 2005 -- Three cycles of CHOP-rituximab (CHOP-R) followed by ibritumomab tiuxetan (Zevalin) and rituximab induces a high rate of ...
Pharmacyclics Announces Presentation and Publication of ... Dec 12, 2005
PR Newswire (press release), 1 clinical trial, which suggest that Xcytrin(R) (motexafin gadolinium) Injection, when given in combination with Zevalin(R) (Ibritumomab Tiuxetan), is well ...
Pharmacyclics Announces Presentation and Publication of ... Dec 12, 2005
Yahoo! News (press release) Phase 1 clinical trial, which suggest that Xcytrin® (motexafin gadolinium) Injection, when given in combination with Zevalin® (Ibritumomab Tiuxetan), is well ...
(PRN) - Option Recognized as a Red Herring Small Cap 100 ... [+] Dec 12, 2005
Bolsamania.com, ...[+]. (PRN) - Chemotherapy Consolidation with Zevalin(R) (90Y-Ibritumomab tiuxetan) May Provide Therapeutic Benefit for Mantle Cell Lymphoma Patients ... [+. ...
Pharmacyclics Announces Presentation and Published Abstracts on ... Dec 6, 2005
PR Newswire (press release), ...are as follows: Sunday, December 11, 2005 Poster Session 654-II Title: Combination of Motexafin Gadolinium (MGd) with 90Y Ibritumomab Tiuxetan (Zevalin(R ...
Pharmacyclics Announces Presentation and Published Abstracts on ... Dec 6, 2005
PharmaLive.com (press release), Title: Combination of Motexafin Gadolinium (MGd) with 90Y Ibritumomab Tiuxetan (Zevalin(R); 90Yttrium-Zevalin) Radioimmunotherapy (RIT) Produces High Complete ...
New Data Demonstrate ZEVALIN(R) Radioimmunotherapy May Play ... Dec 13, 2005
Finanzen.net, The genericname for ZEVALIN is ibritumomab tiuxetan. Today, ZEVALIN is being investigated in a variety of lymphomasubtypes including aggressive disease. ...
|
|
